The evidence gathered indicated that MS is associated with metabolic alterations, particularly a significant increase in glucose levels and response to GTTs, as well as a marked decrease in the QUICKI index, suggesting possible alterations in insulin sensitivity. Here, INS is linked to myeloid sarcoma.